Associated Papers
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer.
McCann K et al.
Journal for Immunotherapy of Cancer, 2022
35361728 (PubMed )
Supplement: jitc-2021-003821supp002.pdf
Clinical and genetic features of the patients with X-Linked agammaglobulinemia from Turkey: Single-centre experience.
Esenboga S et al.
Scandinavian Journal of Immunology, 2018
Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
Carrillo-Tapia E et al.
Expert Review of Clinical Immunology, 2018
Atypical case of X-linked agammaglobulinemia diagnosed at 45 years of age.
Fujioka T et al.
Pediatrics International : Official Journal of the Japan Pediatric Society, 2011
X-linked agammaglobulinemia diagnosed in adulthood: a case report.
Mitsui T et al.
International Journal of Hematology, 2006
[Reversible posterior leukoencephalopathy syndrome probably caused by L-asparaginase].
Miyazawa Y et al.
[rinsho Ketsueki] the Japanese Journal of Clinical Hematology, 2006
Select a paper to view details